Skip to main content
OpenTrials
Completed

NCT Number: NCT03768076

an Istitution Experience on Parosteal OsTeosarcoma

single institution cases series review of histological and clinical data

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Istituto ortopedico Rizzoli

Bologna, 40136, Italy

About this study

Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018
  • Diagnosis of parosteal osteosarcoma
  • Written informed consent prior to any study-specific analysis and/or data collection

Exclusion criteria

  • Patients with histological diagnosis different from parosteal osteosarcoma

Treatment and study plan

Primary outcomes

  1. retrospective analysis of cases of Parosteal osteosarcoma

    Time frame: at baseline (Day0)

    Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Official study title

Parosteal OsTeosarcoma: a Single Istitution Experience

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Dec 7, 2018
Registry last updated
Aug 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.